Analyzing Opposing Interactions Between Sphingosine 1-Phosphate Lyase and Influenza A Virus

被引:2
|
作者
Wolf, Jennifer J. [1 ,2 ]
Saba, Julie D. [3 ]
Hahm, Bumsuk [1 ,2 ]
机构
[1] Univ Missouri, Dept Surg, 1 Hosp Dr, Columbia, MO 65212 USA
[2] Univ Missouri, Dept Mol Microbiol & Immunol, 1 Hosp Dr, Columbia, MO 65212 USA
[3] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA
关键词
sphingosine-1-phosphate lyase; type I interferon; viral immune evasion; influenza A virus; virus-host interactions; NS1; PROTEIN; SPHINGOSINE-1-PHOSPHATE LYASE; I INTERFERON; RNA-BINDING; DEFICIENCY; DEGRADATION; INHIBITION; METABOLISM; ACTIVATION; MUTATIONS;
D O I
10.1089/dna.2022.0071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine 1-phosphate lyase (SPL) is a critical component of sphingosine 1-phosphate (S1P) metabolism. SPL has been associated with several crucial cellular functions due to its role in S1P metabolism, but its role in viral infections is poorly understood. Studies show that SPL has an antiviral function against influenza A virus (IAV) by interacting with IKKe, promoting the type I interferon (IFN) innate immune response to IAV infection. However, a more recent study has revealed that IAV NS1 protein hampers this by triggering ubiquitination and subsequent degradation of SPL, which reduces the type I IFN innate immune response. In this study, we describe SPL, the type I IFN response, and known interactions between SPL and IAV.
引用
收藏
页码:331 / 335
页数:5
相关论文
共 50 条
  • [21] Sphingosine 1-phosphate signalling
    Mendelson, Karen
    Evans, Todd
    Hla, Timothy
    DEVELOPMENT, 2014, 141 (01): : 5 - 9
  • [22] Sphingosine 1-phosphate and inflammation
    Obinata, Hideru
    Hla, Timothy
    INTERNATIONAL IMMUNOLOGY, 2019, 31 (09) : 617 - 625
  • [23] Sphingosine 1-phosphate and cancer
    Nigel J. Pyne
    Susan Pyne
    Nature Reviews Cancer, 2010, 10 : 489 - 503
  • [24] Sphingosine 1-phosphate and cancer
    Pyne, Nigel J.
    Pyne, Susan
    NATURE REVIEWS CANCER, 2010, 10 (07) : 489 - 503
  • [25] Sphingosine Kinase and Sphingosine 1-Phosphate in Cardioprotection
    Karliner, Joel S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 53 (03) : 189 - 197
  • [26] Sphingosine 1-phosphate signaling
    Hla, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 76 - 76
  • [27] The role of sphingosine 1-phosphate/sphingosine 1-phosphate receptor signaling in the pathogenesis of rheumatoid arthritis
    Kitano, M.
    Tam, Y. Y.
    Sekiguchi, M.
    Kuroda, M.
    Kuno, H.
    Kuroiwa, T.
    Hashimoto, N.
    Matsui, K.
    Iwasaki, T.
    Saba, J.
    Hla, T.
    Sano, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 132 - 132
  • [28] Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy
    Atkinson, Derek
    Glumac, Jelena Nikodinovic
    Asselbergh, Bob
    Ermanoska, Biljana
    Blocquel, David
    Steiner, Regula
    Estrada-Cuzcano, Alejandro
    Peeters, Kristien
    Ooms, Tinne
    De Vriendt, Els
    Yang, Xiang-Lei
    Hornemann, Thorsten
    Rasic, Vedrana Milic
    Jordanova, Albena
    NEUROLOGY, 2017, 88 (06) : 533 - 542
  • [29] A facile regioselective synthesis of sphingosine 1-phosphate and ceramide 1-phosphate
    Szulc, ZM
    Hannun, YA
    Bielawska, A
    TETRAHEDRON LETTERS, 2000, 41 (41) : 7821 - 7824
  • [30] Sphingosine 1-phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids
    Uranbileg, Baasanjav
    Kurano, Makoto
    Kano, Kuniyuki
    Sakai, Eri
    Arita, Junichi
    Hasegawa, Kiyoshi
    Nishikawa, Takeshi
    Ishihara, Soichiro
    Yamashita, Hiroharu
    Seto, Yasuyuki
    Ikeda, Hitoshi
    Aoki, Junken
    Yatomi, Yutaka
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (09):